References
M. Arthus,Injections repetees de serum de cheval chez le lapin, C. R. Soc. Biol.55, 817–820 (1903).
R. A. A. Coombs and P. G. H. Gell, Classification of allergic reactions responsible for clinical hypersensitivity and disease. InClinical Aspects of Immunology, pp. 761–781 (Eds. P. G. H. Gell and R. R. A. Coombs). Blackwell (1968).
C. G. Cochrane,Mediators of the Arthus and related reactions, Prog. Allerg.11, 1–35 (1967).
C. V. DeShazo, P. M. Henson and C. G. Cochrane,Acute immunologic arthritis in rabbits. J. Clin. Invest.51, 50–57 (1972).
C. G. Cochrane and A. Janoff, The Arthus reaction: a model of neutrophil and complement-mediated injury. InThe inflammatory process, Vol. III, pp. 85–162 (Eds B. W. Zweifach, L. Grant and R. T. McCluskey). Academic Press, New York (1974).
K. J. Johnson and P. A. Ward,Acute immunologic pulmonary alveolitis. J. Clin. Invest.54, 349–357 (1974).
J. P. Crawford, H. Z. Movat, J. O. Minta, and M. Opas,Acute inflammation induced by immune complexes in the microcirculation. Exp. Mol. Pathol.42, 175–193 (1985).
P. J. Jose, M. J. Forrest and T. J. Williams,Detection of the complement fragment C5a in inflammatory exudates from the rabbit peritoneal cavity using radioimmunoassay, J. Exp. Med.158, 2177–2182 (1983).
T. J. Williams,Prostaglandin E 2 ,prostaglandin I 2 and the vascular changes in inflammation. Br. J. Pharmac.65, 517–524 (1979).
T. J. Williams and P. J. Jose,Mediation of increased vascular permeability after complement activation; histamine-independent action of rabbit C5a. J. Exp. Med.153, 136–153 (1981).
C. V. Wedmore and T. J. Williams,Control of vascular permeability by polymorphonuclear leukocytes in inflammation. Nature289, 646–650 (1981).
T. J. Williams and M. J. Peck,Role of prostaglandin-mediated vasodilatation in inflammation. Nature270, 530–532 (1977).
H. J. Muller-Eberhard, The complement system. InThe Plasma Proteins, Vol. I, pp. 393–432 (Ed. F. W. Putnam). Academic Press, London (1975).
T. E. Hugli and H. J. Muller-Eberhard,Anaphylatoxins: C3a and C5a. Adv. Immunol.26 1–53 (1978).
T. J. Williams,A proposed mediator of increased vascular permeability in acute inflammation in the rabbit. J. Physiol. (Lond.)281, 44P (1978).
P. J. Jose, M. J. Forrest and T. J. Williams,Human C5a des Arg increases vascular permeability. J. Immunol.127, 1276–1280 (1981).
C. G. Cochrane, H. J. Muller-Eberhard and B. S. Aikin,Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions, J. Immunol.105, 55–69 (1970).
C. A. Stetson,Similarities in the mechanisms determining the Arthus and Shwartzman phenomena. J. Exp. Med.94, 347–358 (1951).
J. H. Humphrey,The mechanisms of Arthus reactions. I. The role of polymorphonuclear leucocytes and other factors in reversed passive Arthus reactions in rabbits. Br. J. Exp. Pathol.36, 268–282 (1955).
R. N. Pinckard, L. M. McManus and D. J. Hanahan, Chemistry and biology of acetylglyceryl ether phosphorylcholine (platelet-activating factor). InAdvances in Inflammation Research, Vol. 4, pp. 147–180 (Ed. G. Weissmann). Raven Press, New York (1982).
G. Camussi, M. Aglietta, F. Malvasi, C. Tetta, W. Piacibello, F. Sanavio and F. Bussolino,The release of platelet-activating factor from human endothelial cells in culture. J. Immunol.131, 2397–2403 (1983).
C. V. Wedmore and T.J. Williams,Platelet-activating factor (PAF), a secretory product of polymorphonuclear leukocytes, increases vascular permeability in rabbit skin. Br. J. Pharmac.74, 916P (1981).
S.-B. Hwang, M.-H. Lam, T. Biftu and T.-Y. Shen,A synthetic competitive and specific antagonist of platelet-activating factor. Fed. Proc.44, 1435 (1985).
S. Dequand, J. Lefort, J. Deregnaucourt, P. Sedivy, V. Lagente, J. Randon and B. B. Vargfaftig,Inhibition by the PAF acether antagonist 48740 RP of the bronchopulmonary effects of PAF-acether. Int. J. Immunopharmacol.3, 383 (1985).
P. G. Hellewell and T. J. Williams,Suppression of inflammatory oedema in rabbit skin by two PAF antagonists 48740 RP and L-652731. Prostaglandins30, 713 (1985).
P. G. Hellewell and T. J. Williams,Inhibition of allergic inflammation by PAF antagonists in the rabbit. Br. J. Pharmac.86, 527P (1985).
G. Camussi, C. Tetta, F. Bussolino, F. Callagis Cappio, R. Coda, C. Masera and G. Segoloni,Mediators of immunecomplex-induced aggregation of polymorphonuclear neutrophils. II. Platelet-activating factor as the effector substance of immune-induced aggregation. Int. Archs. Allergy. appl. Immunol.64, 25–41 (1981).
T. J. Williams and P. J. Piper,The action of chemically pure SRS-A on the microvasculature in vivo, Prostaglandins19, 779–789 (1980).
J. M. Drazen, K. F. Austen, R. A. Lewis, D. A. Clark, G. Goto, A. Marfat and E. J. Corey,Comparative airway and vascular activities of leukotrienes C-1 and D in vivo and in vitro. Proc. Natl. Acad. Sci. USA.77, 4354–4358 (1980).
M. J. Peck, P. J. Piper and T. J. Williams,The effect of leukotrienes C 4 and D 4 on the microvasculature of guinea-pig skin, Prostaglandins21, 315–321 (1981).
P. A. Ward and J. H. Hill,C5 chemotactic fragments produced by an enzyme in lysosomal granules of neutrophils. J. Immunol.104, 535–543 (1970).
P. A. Ward and J. H. Hill,Biologic role of complement products. Complement-derived leukotactic activity extractable from lesions of immunologic vasculitis. J. Immunol.108, 1137–1145 (1972).
J. C. Fantone, S. L. Kunkel and P. A. Ward,Chemotactic mediators in neutrophil-dependent lung injury. Ann. Rev. Physiol.44, 283–293 (1982).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Williams, T.J., Hellewell, P.G. & Jose, P.J. Inflammatory mechanisms in the Arthus reaction. Agents and Actions 19, 66–72 (1986). https://doi.org/10.1007/BF01977260
Issue Date:
DOI: https://doi.org/10.1007/BF01977260